Ernexa Therapeutics Inc. Liabilities, Noncurrent
Ernexa Therapeutics Inc. (ERNA) had Liabilities, Noncurrent of $500.00 thousand as of 2012-06-30, per its 10-Q filed 2012-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2012-08-14
- 2012-06-30: Liabilities, Noncurrent $500.00K.
- 2011-12-31: Liabilities, Noncurrent $604.00K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2012-06-30 | $500.00K 10-Q · filed 2012-08-14 |
| 2011-12-31 | $604.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |